Studying Cancer as an Adverse Outcome from Nononcological Therapies

Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract

Midkiff, K., Harris, D., Gilsenan, A., & Andrews, E. (2015). Studying Cancer as an Adverse Outcome from Nononcological Therapies: Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract. Pharmacoepidemiology and Drug Safety, 24(S1), 448-449. https://doi.org/10.1002/pds.3838

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments
Article

Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052
Article

The influence of mediators on the relationship between antenatal opioid agonist exposure and the severity of neonatal opioid withdrawal syndrome